Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Fosun, Chindex and PE Fund Buy Israeli Aesthetic Device Company

publication date: Apr 29, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Fosun Pharma, Chindex and a private equity partner will spend up to $240 million to buy 95.6% of an Israeli medical device company, Alma Lasers. Alma, which had revenues of about $100 million last year, makes lasers and other products, primarily for aesthetic procedures. Fosun said the investment represented a growing internationalization of its operations. More details....

Stock Symbols: (SH: 600196; HK: 02196) (NSDQ: CHDX)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners